Review the technical requirements for transitioning short-shelf-life cell therapies away from direct inoculation ...
Background Timely and appropriate diagnosis and treatment are key to ending tuberculosis (TB). Incorporating users’ ...
hVIVO to conduct world's first pivotal Phase III human challenge whooping cough vaccine trial for ILiAD Biotechnologies · World's first pivotal Phase III human challenge trial ("HCT") in Bordetella ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results